https://www.indianpharmapost.com/shilpas-unit-2-passes-second-consecutive-fda-inspection-with-no-483s-169982025-04-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/zim-laboratories-and-globalpharma-collaborate-to-commercialize-oral-thin-film-products-in-gcc-169992025-04-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/curateq-biologics-completes-phase-1-pharmacokinetics-study-of-biosimilar-denosumab-170002025-04-09T00:00:00+05:30always0.9